These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2694536)

  • 1. New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects.
    Boddeke E; Hugtenburg J; Jap W; Heynis J; van Zwieten P
    Trends Pharmacol Sci; 1989 Oct; 10(10):397-400. PubMed ID: 2694536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and clinical aspects of drug therapy in coronary heart disease: clinical aspects of therapy with beta-adrenoceptor antagonists.
    Prichard BN
    Z Kardiol; 1990; 79 Suppl 3():99-103. PubMed ID: 1983055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone. Haemodynamic profile during intravenous administration and effect on pacing-induced ischaemia in man.
    Remme WJ; van Hoogenhuyze DC; Kruyssen DA; Krauss XH; Storm CJ
    Drugs; 1985 Mar; 29 Suppl 3():11-22. PubMed ID: 3996243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.
    Silber S; Vogler AC; Krause KH; Theisen K
    Drugs; 1987; 33 Suppl 4():69-79. PubMed ID: 3622317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds G; Taylor SH
    Eur J Clin Pharmacol; 1986; 29(6):659-65. PubMed ID: 2872054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of a new anti-arrhythmic agent, mexiletine (Kö 1173) in ischaemic heart disease.
    Saunamäki
    Cardiovasc Res; 1975 Nov; 9(6):788-92. PubMed ID: 1203917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
    Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
    Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and the ischaemic myocardium.
    Fox KM; Levy RD; Mockus L; Wright C
    J Hypertens Suppl; 1987 Aug; 5(3):S17-8. PubMed ID: 3312524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic dose-response effects of UK-52,046 in ischaemic disease with or without impaired left ventricular function.
    Silke B; Zezulka AV; Verma SP; Tham TC; Taylor SH
    Br J Clin Pharmacol; 1990 Jun; 29(6):749-58. PubMed ID: 1974144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of a series of anti-anginal agents in a novel canine model of transient myocardial ischaemia.
    Allely MC; Alps BJ
    Br J Pharmacol; 1989 Apr; 96(4):977-85. PubMed ID: 2743088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrous oxide augments the systemic and coronary haemodynamic effects of isoflurane in patients with ischaemic heart disease.
    Reiz S
    Acta Anaesthesiol Scand; 1983 Dec; 27(6):464-9. PubMed ID: 6421078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptor blockade and intrinsic sympathomimetic activity--relevance in the treatment of ischaemic heart disease.
    Northcote RJ; Ballantyne D
    Scott Med J; 1985 Oct; 30(4):208-15. PubMed ID: 2869581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short and long term administration of amiodarone on ischaemia-induced left ventricular dysfunction. Implications for combined antianginal drug therapy.
    Pfisterer M; Burkart F
    Drugs; 1985 Mar; 29 Suppl 3():23-9. PubMed ID: 3922732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Amlor-Holter Study Investigators.
    Madjlessi-Simon T; Fillette F; Mary-Krause M; Lechat P; Jaillon P
    Eur Heart J; 1995 Dec; 16(12):1780-8. PubMed ID: 8682007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists and coronary heart disease. An overview].
    Gasser R; Eber B; Schwarz T; Schafhalter E; Klein W
    Wien Med Wochenschr; 1993; 143(19-20):500-9. PubMed ID: 8135032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The present status of nitrates in the treatment of ischemic heart disease].
    Stejfa M; Vítovec J
    Vnitr Lek; 1993 Feb; 39(2):172-7. PubMed ID: 8506665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of intravenous beta-blocking drugs in coronary heart disease.
    Taylor SH; Silke B; Nelson GI
    J Pharmacol; 1983; 14 Suppl 2():157-67. PubMed ID: 6138465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of bisoprolol in patients with coronary heart disease: influence of various bisoprolol plasma concentrations.
    Bonelli J; Staribacher H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S83-6. PubMed ID: 2439805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.